- •Contents
- •Contributors
- •Part I General Principles of Cell Death
- •1 Human Caspases – Apoptosis and Inflammation Signaling Proteases
- •1.1. Apoptosis and limited proteolysis
- •1.2. Caspase evolution
- •2. ACTIVATION MECHANISMS
- •2.2. The activation platforms
- •2.4. Proteolytic maturation
- •3. CASPASE SUBSTRATES
- •4. REGULATION BY NATURAL INHIBITORS
- •REFERENCES
- •2 Inhibitor of Apoptosis Proteins
- •2. CELLULAR FUNCTIONS AND PHENOTYPES OF IAP
- •3. IN VIVO FUNCTIONS OF IAP FAMILY PROTEINS
- •4. SUBCELLULAR LOCATIONS OF IAP
- •8. IAP–IAP INTERACTIONS
- •10. ENDOGENOUS ANTAGONISTS OF IAP
- •11. IAPs AND DISEASE
- •SUGGESTED READINGS
- •1. INTRODUCTION
- •2.1. The CD95 (Fas/APO-1) system
- •2.1.1. CD95 and CD95L: discovery of the first direct apoptosis-inducing receptor-ligand system
- •2.1.2. Biochemistry of CD95 apoptosis signaling
- •2.2. The TRAIL (Apo2L) system
- •3.1. The TNF system
- •3.1.1. Biochemistry of TNF signal transduction
- •3.1.2. TNF and TNF blockers in the clinic
- •3.2. The DR3 system
- •4. THE DR6 SYSTEM
- •6. CONCLUDING REMARKS AND OUTLOOK
- •SUGGESTED READINGS
- •4 Mitochondria and Cell Death
- •1. INTRODUCTION
- •2. MITOCHONDRIAL PHYSIOLOGY
- •3. THE MITOCHONDRIAL PATHWAY OF APOPTOSIS
- •9. CONCLUSIONS
- •SUGGESTED READINGS
- •1. INTRODUCTION
- •3. INHIBITING APOPTOSIS
- •4. INHIBITING THE INHIBITORS
- •6. THE BCL-2 FAMILY AND CANCER
- •SUGGESTED READINGS
- •6 Endoplasmic Reticulum Stress Response in Cell Death and Cell Survival
- •1. INTRODUCTION
- •2. THE ESR IN YEAST
- •3. THE ESR IN MAMMALS
- •4. THE ESR AND CELL DEATH
- •5. THE ESR IN DEVELOPMENT AND TISSUE HOMEOSTASIS
- •6. THE ESR IN HUMAN DISEASE
- •7. CONCLUSION
- •7 Autophagy – The Liaison between the Lysosomal System and Cell Death
- •1. INTRODUCTION
- •2. AUTOPHAGY
- •2.2. Physiologic functions of autophagy
- •2.3. Autophagy and human pathology
- •3. AUTOPHAGY AND CELL DEATH
- •3.1. Autophagy as anti–cell death mechanism
- •3.2. Autophagy as a cell death mechanism
- •3.3. Molecular players of the autophagy–cell death cross-talk
- •4. AUTOPHAGY, CELLULAR DEATH, AND CANCER
- •5. CONCLUDING REMARKS AND PENDING QUESTIONS
- •SUGGESTED READINGS
- •8 Cell Death in Response to Genotoxic Stress and DNA Damage
- •1. TYPES OF DNA DAMAGE AND REPAIR SYSTEMS
- •2. DNA DAMAGE RESPONSE
- •2.2. Transducers
- •2.3. Effectors
- •4. CHROMATIN MODIFICATIONS
- •5. CELL CYCLE CHECKPOINT REGULATION
- •6. WHEN REPAIR FAILS: SENESCENCE VERSUS APOPTOSIS
- •6.1. DNA damage response and the induction of apoptosis
- •6.2. p53-independent mechanisms of apoptosis
- •6.3. DNA damage response and senescence induction
- •7. DNA DAMAGE FROM OXIDATIVE STRESS
- •SUGGESTED READINGS
- •9 Ceramide and Lipid Mediators in Apoptosis
- •1. INTRODUCTION
- •3.1. Basic cell signaling often involves small molecules
- •3.2. Sphingolipids are cell-signaling molecules
- •3.2.1. Ceramide induces apoptosis
- •3.2.2. Ceramide accumulates during programmed cell death
- •3.2.3. Inhibition of ceramide production alters cell death signaling
- •4.1. Ceramide is generated through SM hydrolysis
- •4.3. aSMase can be activated independently of extracellular receptors to regulate apoptosis
- •4.4. Controversial aspects of the role of aSMase in apoptosis
- •4.5. De novo ceramide synthesis regulates programmed cell death
- •4.6. p53 and Bcl-2–like proteins are connected to de novo ceramide synthesis
- •4.7. The role and regulation of de novo synthesis in ceramide-mediated cell death is poorly understood
- •5. CONCLUDING REMARKS AND FUTURE DIRECTIONS
- •5.1. Who? (Which enzyme?)
- •5.2. What? (Which ceramide?)
- •5.3. Where? (Which compartment?)
- •5.4. When? (At what steps?)
- •5.5. How? (Through what mechanisms?)
- •5.6. What purpose?
- •6. SUMMARY
- •SUGGESTED READINGS
- •1. General Introduction
- •1.1. Cytotoxic lymphocytes and apoptosis
- •2. CYTOTOXIC GRANULES AND GRANULE EXOCYTOSIS
- •2.1. Synthesis and loading of the cytotoxic granule proteins into the secretory granules
- •2.2. The immunological synapse
- •2.3. Secretion of granule proteins
- •2.4. Uptake of proapoptotic proteins into the target cell
- •2.5. Activation of death pathways by granzymes
- •3. GRANULE-BOUND CYTOTOXIC PROTEINS
- •3.1. Perforin
- •3.2. Granulysin
- •3.3. Granzymes
- •3.3.1. GrB-mediated apoptosis
- •3.3.2. GrA-mediated cell death
- •3.3.3. Orphan granzyme-mediated cell death
- •5. CONCLUSIONS
- •REFERENCES
- •Part II Cell Death in Tissues and Organs
- •1.1. Death by trophic factor deprivation
- •1.2. Key molecules regulating neuronal apoptosis during development
- •1.2.1. Roles of caspases and Apaf-1 in neuronal cell death
- •1.2.2. Role of Bcl-2 family members in neuronal cell death
- •1.3. Signal transduction from neurotrophins and neurotrophin receptors
- •1.3.1. Signals for survival
- •1.3.2. Signals for death
- •2.1. Apoptosis in neurodegenerative diseases
- •2.1.4. Amyotrophic lateral sclerosis
- •2.2. Necrotic cell death in neurodegenerative diseases
- •2.2.1. Calpains
- •2.2.2. Cathepsins
- •3. CONCLUSIONS
- •ACKNOWLEDGMENT
- •SUGGESTED READINGS
- •ACKNOWLEDGMENT
- •SUGGESTED READINGS
- •1. INTRODUCTION
- •5. S-NITROSYLATION OF PARKIN
- •7. POTENTIAL TREATMENT OF EXCESSIVE NMDA-INDUCED Ca2+ INFLUX AND FREE RADICAL GENERATION
- •8. FUTURE THERAPEUTICS: NITROMEMANTINES
- •9. CONCLUSIONS
- •Acknowledgments
- •SUGGESTED READINGS
- •3. MITOCHONDRIAL PERMEABILITY TRANSITION ACTIVATED BY Ca2+ AND OXIDATIVE STRESS
- •4.1. Mitochondrial apoptotic pathways
- •4.2. Bcl-2 family proteins
- •4.3. Caspase-dependent apoptosis
- •4.4. Caspase-independent apoptosis
- •4.5. Calpains in ischemic neural cell death
- •5. SUMMARY
- •ACKNOWLEDGMENTS
- •SUGGESTED READINGS
- •1. INTRODUCTION
- •2. HISTORICAL ANTECEDENTS
- •7.1. Activation of p21 waf1/cip1: Targeting extrinsic and intrinsic pathways to death
- •8. CONCLUSION
- •ACKNOWLEDGMENTS
- •REFERENCES
- •16 Apoptosis and Homeostasis in the Eye
- •1.1. Lens
- •1.2. Retina
- •2. ROLE OF APOPTOSIS IN DISEASES OF THE EYE
- •2.1. Glaucoma
- •2.2. Age-related macular degeneration
- •4. APOPTOSIS AND OCULAR IMMUNE PRIVILEGE
- •5. CONCLUSIONS
- •SUGGESTED READINGS
- •17 Cell Death in the Inner Ear
- •3. THE COCHLEA IS THE HEARING ORGAN
- •3.1. Ototoxic hair cell death
- •3.2. Aminoglycoside-induced hair cell death
- •3.3. Cisplatin-induced hair cell death
- •3.4. Therapeutic strategies to prevent hair cell death
- •3.5. Challenges to studies of hair cell death
- •4. SPIRAL GANGLION NEURON DEATH
- •4.1. Neurotrophic support from sensory hair cells and supporting cells
- •4.2. Afferent activity from hair cells
- •4.3. Molecular manifestations of spiral ganglion neuron death
- •4.4. Therapeutic interventions to prevent SGN death
- •ACKNOWLEDGMENTS
- •SUGGESTED READINGS
- •18 Cell Death in the Olfactory System
- •1. Introduction
- •2. Anatomical Aspects
- •3. Life and Death in the Olfactory System
- •3.1. Olfactory epithelium
- •3.2. Olfactory bulb
- •REFERENCES
- •1. Introduction
- •3.1. Beta cell death in the development of T1D
- •3.2. Mechanisms of beta cell death in type 1 diabetes
- •3.2.1. Apoptosis signaling pathways downstream of death receptors and inflammatory cytokines
- •3.2.2. Oxidative stress
- •3.3. Mechanisms of beta cell death in type 2 diabetes
- •3.3.1. Glucolipitoxicity
- •3.3.2. Endoplasmic reticulum stress
- •5. SUMMARY
- •Acknowledgments
- •REFERENCES
- •20 Apoptosis in the Physiology and Diseases of the Respiratory Tract
- •1. APOPTOSIS IN LUNG DEVELOPMENT
- •2. APOPTOSIS IN LUNG PATHOPHYSIOLOGY
- •2.1. Apoptosis in pulmonary inflammation
- •2.2. Apoptosis in acute lung injury
- •2.3. Apoptosis in chronic obstructive pulmonary disease
- •2.4. Apoptosis in interstitial lung diseases
- •2.5. Apoptosis in pulmonary arterial hypertension
- •2.6. Apoptosis in lung cancer
- •SUGGESTED READINGS
- •21 Regulation of Cell Death in the Gastrointestinal Tract
- •1. INTRODUCTION
- •2. ESOPHAGUS
- •3. STOMACH
- •4. SMALL AND LARGE INTESTINE
- •5. LIVER
- •6. PANCREAS
- •7. SUMMARY AND CONCLUDING REMARKS
- •SUGGESTED READINGS
- •22 Apoptosis in the Kidney
- •1. NORMAL KIDNEY STRUCTURE AND FUNCTION
- •3. APOPTOSIS IN ADULT KIDNEY DISEASE
- •4. REGULATION OF APOPTOSIS IN KIDNEY CELLS
- •4.1. Survival factors
- •4.2. Lethal factors
- •4.2.1. TNF superfamily cytokines
- •4.2.2. Other cytokines
- •4.2.3. Glucose
- •4.2.4. Drugs and xenobiotics
- •4.2.5. Ischemia-reperfusion and sepsis
- •5. THERAPEUTIC APPROACHES
- •SUGGESTED READINGS
- •1. INTRODUCTION
- •2. APOPTOSIS IN THE NORMAL BREAST
- •2.1. Occurrence and role of apoptosis in the developing breast
- •2.2.2. Death ligands and death receptor pathway
- •2.2.4. LIF-STAT3 proapoptotic signaling
- •2.2.5. IGF survival signaling
- •2.2.6. Regulation by adhesion
- •2.2.7. PI3K/AKT pathway: molecular hub for survival signals
- •2.2.8. Downstream regulators of apoptosis: the BCL-2 family members
- •3. APOPTOSIS IN BREAST CANCER
- •3.1. Apoptosis in breast tumorigenesis and cancer progression
- •3.2. Molecular dysregulation of apoptosis in breast cancer
- •3.2.1. Altered expression of death ligands and their receptors in breast cancer
- •3.2.2. Deregulation of prosurvival growth factors and their receptors
- •3.2.3. Alterations in cell adhesion and resistance to anoikis
- •3.2.4. Enhanced activation of the PI3K/AKT pathway in breast cancer
- •3.2.5. p53 inactivation in breast cancer
- •3.2.6. Altered expression of BCL-2 family of proteins in breast cancer
- •5. CONCLUSION
- •SUGGESTED READINGS
- •1. INTRODUCTION
- •2. DETECTING CELL DEATH IN THE FEMALE GONADS
- •4. APOPTOSIS AND FEMALE REPRODUCTIVE AGING
- •6. CONCLUDING REMARKS
- •REFERENCES
- •25 Apoptotic Signaling in Male Germ Cells
- •1. INTRODUCTION
- •3.1. Murine models
- •3.2. Primate models
- •3.3. Pathways of caspase activation and apoptosis
- •3.4. Apoptotic signaling in male germ cells
- •5. P38 MITOGEN-ACTIVATED PROTEIN KINASE (MAPK) AND NITRIC OXIDE (NO)–MEDIATED INTRINSIC PATHWAY SIGNALING CONSTITUTES A CRITICAL COMPONENT OF APOPTOTIC SIGNALING IN MALE GERM CELLS AFTER HORMONE DEPRIVATION
- •11. CONCLUSIONS AND PERSPECTIVES
- •REFERENCES
- •26 Cell Death in the Cardiovascular System
- •1. INTRODUCTION
- •2. CELL DEATH IN THE VASCULATURE
- •2.1. Apoptosis in the developing blood vessels
- •2.2. Apoptosis in atherosclerosis
- •2.2.1. Vascular smooth muscle cells
- •2.2.2. Macrophages
- •2.2.3. Regulation of apoptosis in atherosclerosis
- •2.2.4. Necrosis and autophagy in atherosclerosis
- •3. CELL DEATH IN THE MYOCARDIUM
- •3.1. Cell death in myocardial infarction
- •3.1.1. Apoptosis in myocardial infarction
- •3.1.2. Necrosis in myocardial infarction
- •3.1.3. Autophagy in myocardial infarction
- •3.2. Cell death in heart failure
- •3.2.1. Apoptosis in heart failure
- •3.2.2. Necrosis in heart failure
- •3.2.3. Autophagy in heart failure
- •4. CONCLUDING REMARKS
- •ACKNOWLEDGMENTS
- •REFERENCES
- •27 Cell Death Regulation in Muscle
- •1. INTRODUCTION TO MUSCLE
- •1.1. Skeletal muscle adaptation to endurance training
- •1.2. Myonuclear domains
- •2. MITOCHONDRIALLY MEDIATED APOPTOSIS IN MUSCLE
- •2.1. Skeletal muscle apoptotic susceptibility
- •4. APOPTOSIS IN MUSCLE DURING AGING AND DISEASE
- •4.1. Aging
- •4.2. Type 2 diabetes mellitus
- •4.3. Cancer cachexia
- •4.4. Chronic heart failure
- •6. CONCLUSION
- •SUGGESTED READINGS
- •28 Cell Death in the Skin
- •1. INTRODUCTION
- •2. CELL DEATH IN SKIN HOMEOSTASIS
- •2.1. Cornification and apoptosis
- •2.2. Death receptors in the skin
- •3. CELL DEATH IN SKIN PATHOLOGY
- •3.1. Sunburn
- •3.2. Skin cancer
- •3.3. Necrolysis
- •3.4. Pemphigus
- •3.5. Eczema
- •3.6. Graft-versus-host disease
- •4. CONCLUDING REMARKS AND PERSPECTIVES
- •ACKNOWLEDGMENTS
- •SUGGESTED READINGS
- •29 Apoptosis and Cell Survival in the Immune System
- •2.1. Survival of early hematopoietic progenitors
- •2.2. Sizing of the T-cell population
- •2.2.1. Establishing central tolerance
- •2.2.2. Peripheral tolerance
- •2.2.3. Memory T cells
- •2.3. Control of apoptosis in B-cell development
- •2.3.1. Early B-cell development
- •2.3.2. Deletion of autoreactive B cells
- •2.3.3. Survival and death of activated B cells
- •3. IMPAIRED APOPTOSIS AND LEUKEMOGENESIS
- •4. CONCLUSIONS
- •ACKNOWLEDGMENTS
- •REFERENCES
- •30 Cell Death Regulation in the Hematopoietic System
- •1. INTRODUCTION
- •2. HEMATOPOIETIC STEM CELLS
- •4. ERYTHROPOIESIS
- •5. MEGAKARYOPOIESIS
- •6. GRANULOPOIESIS
- •7. MONOPOIESIS
- •8. CONCLUSION
- •ACKNOWLEDGMENTS
- •REFERENCES
- •31 Apoptotic Cell Death in Sepsis
- •1. INTRODUCTION
- •2. HOST INFLAMMATORY RESPONSE TO SEPSIS
- •3. CLINICAL OBSERVATIONS OF CELL DEATH IN SEPSIS
- •3.1. Sepsis-induced apoptosis
- •3.2. Necrotic cell death in sepsis
- •4.1. Central role of apoptosis in sepsis mortality: immune effector cells and gut epithelium
- •4.2. Apoptotic pathways in sepsis-induced immune cell death
- •4.3. Investigations implicating the extrinsic apoptotic pathway in sepsis
- •4.4. Investigations implicating the intrinsic apoptotic pathway in sepsis
- •5. THE EFFECT OF APOPTOSIS ON THE IMMUNE SYSTEM
- •5.1. Cellular effects of an increased apoptotic burdens
- •5.2. Network effects of selective loss of immune cell types
- •5.3. Studies of immunomodulation by apoptotic cells in other fields
- •7. CONCLUSION
- •REFERENCES
- •32 Host–Pathogen Interactions
- •1. INTRODUCTION
- •2. FROM THE PATHOGEN PERSPECTIVE
- •2.1. Commensals versus pathogens
- •2.2. Pathogen strategies to infect the host
- •3. HOST DEFENSE
- •3.1. Antimicrobial peptides
- •3.2. PRRs and inflammation
- •3.2.1. TLRs
- •3.2.2. NLRs
- •3.2.3. The Nod signalosome
- •3.2.4. The inflammasome
- •3.3. Cell death
- •3.3.1. Apoptosis and pathogen clearance
- •3.3.2. Pyroptosis
- •3.2.3. Caspase-independent cell death
- •3.2.4. Autophagy and autophagic cell death
- •4. CONCLUSIONS
- •REFERENCES
- •Part III Cell Death in Nonmammalian Organisms
- •1. PHENOTYPE AND ASSAYS OF YEAST APOPTOSIS
- •2.1. Pheromone-induced cell death
- •2.1.1. Colony growth
- •2.1.2. Killer-induced cell death
- •3. EXTERNAL STIMULI THAT INDUCE APOPTOSIS IN YEAST
- •4. THE GENETICS OF YEAST APOPTOSIS
- •5. PROGRAMMED AND ALTRUISTIC AGING
- •SUGGESTED READINGS
- •34 Caenorhabditis elegans and Apoptosis
- •1. Overview
- •2. KILLING
- •3. SPECIFICATION
- •4. EXECUTION
- •4.1. DNA degradation
- •4.2. Mitochondrial elimination
- •4.3. Engulfment
- •5. SUMMARY
- •SUGGESTED READINGS
- •35 Apoptotic Cell Death in Drosophila
- •2. DROSOPHILA CASPASES AND PROXIMAL REGULATORS
- •6. CLOSING COMMENTS
- •SUGGESTED READINGS
- •36 Analysis of Cell Death in Zebrafish
- •1. INTRODUCTION
- •2. WHY USE ZEBRAFISH TO STUDY CELL DEATH?
- •2.2. Molecular techniques to rapidly assess gene function in embryos
- •2.2.1. Studies of gene function using microinjections into early embryos
- •2.2.2. In situ hybridization and immunohistochemistry
- •2.3. Forward genetic screening
- •2.4. Drug and small-molecule screening
- •2.5. Transgenesis
- •2.6. Targeted knockouts
- •3.1. Intrinsic apoptosis
- •3.2. Extrinsic apoptosis
- •3.3. Chk-1 suppressed apoptosis
- •3.4. Anoikis
- •3.5. Autophagy
- •3.6. Necrosis
- •4. DEVELOPMENTAL CELL DEATH IN ZEBRAFISH EMBRYOS
- •5. THE P53 PATHWAY
- •6. PERSPECTIVES AND FUTURE DIRECTIONS
- •SUGGESTED READING
392 |
VALTER D. LONGO AND CRISTINA MAZZONI |
Figure 33-2. Aging and programmed cell death in yeast. The Ras and Sch9 pathways have been shown to regulate age-dependent programmed cell death in S. cerevisiae in part by controlling superoxide generation and stress resistance systems. Homologs of genes that a ect PCD in yeast (SODs, cytochrome c, caspase) are also implicated in mammalian apoptosis.
they also could be directed to the design of new antifungal drugs. A new generation of antifungal drugs is required for many reasons, including the limitations associated with those currently in use and the increasing number of invasive fungal infections in immunocompromised patients. Thus the exploration of yeast PCD processes to identify molecules that trigger yeast cell death without causing serious side effects in human cells is extremely important.
4. THE GENETICS OF YEAST APOPTOSIS
Although a variety of toxins can promote apoptosis in S. cerevisiae, features of PCD were first described in yeast cells carrying the S565G substitution in the second ATPase domain (D2) of the CDC48 gene, which codes for the AAA-ATPase and plays a role in cell division, ubiquitin-dependent endoplasmic reticulum– associated protein degradation (ERAD), and vesicle trafficking. Later on, it was observed that mutations in the VCP (valosin-containing protein), the metazoan homolog of the yeast CDC48, gave rise to apoptotic phenotypes in mammalian cell culture, in trypanosomes, Drosophila, and zebra fish. Moreover, mutations in VPC also trigger the human multisystem disorder called inclusion body myopathy associated with Paget’s disease of bone and frontotemporal dementia (IBMPFD). More recently, other mutants in numerous cellular
fundamental processes, such as DNA replication, mitochondrial function, RNA, and protein stability, showed apoptotic phenotypes. These findings support the value of yeast as a model organism to study evolutionarily conserved mechanisms of apoptotic regulation.
5. PROGRAMMED AND ALTRUISTIC AGING
Much of the skepticism for the existence of apoptosis in yeast was supported by the apparent lack of an evolutionary base for the suicide of an organism. Perhaps one of the most convincing types of apoptosis in S. cerevisiae is that consistently observed during aging of yeast populations in a medium similar to that encountered in natural environments. Wild-type yeast aging chronologically in glucose/ethanol medium show features of apoptotic death such as generation of superoxide, nuclear condensation/fragmentation, and phosphatidylserine exposure; meta-caspase activation is also seen in some contents. ROS formation is enhanced in old cells, in agreement with a crucial role for superoxide in the mediation of yeast apoptosis during aging (see the remaining text in this section and Figure 33-2). Almeida et al. (2007) have recently provided evidence for the production of nitric oxide (NO) in aging yeast. According to their studies, NO contributes to superoxide production, and its removal by treatment with oxyhemoglobin, an
PROGRAMMED CELL DEATH IN THE YEAST SACCHAROMYCES CEREVISIAE |
393 |
NO scavenger, extends the CLS (chronological life span) of wild-type cells. A number of genetic interventions that delay chronological aging and the appearance of the apoptotic features associated with it have been described. Among these are the disruption of the yeast meta-caspase YCA1 gene and of NDI1 (coding for the yeast homolog of the AIF-homologous mitochondrion associated inducer of death, AMID) and the overexpression of the stress-dependent transcription factor Yap1, although the most effective mutations known to block age-dependent apoptosis are the deletion of either RAS2 or SCH9 or both, which prolong the mean CLS by up to fivefold (Fabrizio et al., 2003; Fabrizio et al., 2001).
A nongenetic intervention that delays PCD and extends survival in wild-type yeast is calorie restriction/starvation obtained by switching yeast to water after growth in glucose medium (SDC [synthetic dextrose complete]). Starvation, as well as the reduction of the glucose concentration in the medium, can double the survival of S. cerevisiae, which suggests that yeast apoptosis depends on the type of environment encountered by the organism. Similar phenotypes including stress resistance and extended survival are shared between starved or ethanol-depleted cells and most of the long-lived mutants, including those lacking SCH9 or RAS2. When aging wild-type cells incubated in glucose medium (SDC) are compared with long-lived sch9 and ras2 mutants, besides the apoptotic markers, major differences in stress response are observed. Both sch9 and ras2 mutants are less susceptible to oxidative stress than wild-type cells. Their resistance to oxidants depends in part on the expression of SOD2.
The presence of apoptotic markers and the role of nutrients and signal transduction pathways involved in nutrient signaling led to our hypothesis that aging S. cerevisiae activates a program that blocks cell protection and accelerates the death of the cells. The existence of such a program would be unlikely based on evolutionary theories, which rule out that a unicellular organism can activate a program that benefits other organisms. However, several lines of evidence have indicated that, for a population of millions or billions of yeast that have encountered an environment in which extracellular nutrients are scarce, cellular “suicide” represents a “group-level survival strategy.” In fact, in approximately 50% of the aging wild-type cultures studied, cellular “regrowth” is observed (colony-forming units increase by up to 100 folds) after the great majority of the population has died. The percent of regrowth reaches more than 80% for cultures of mutants lacking SOD1, which codes for the cytosolic superoxide dismutase, suggesting a direct correlation between intracellular superoxide and frequency of regrowth. The regrowth phenotype, which
we called “adaptive regrowth,” has been characterized extensively. Its characteristics are (1) correlation with frequency of nuclear mutations, which accumulate during aging, and (2) requirement for the nutrients released by the dead cells into the medium. Both features appear to be promoted by both cytoplasmic and mitochondrial superoxide, which, on the one hand, promotes accelerated cell death and consequently the release of nutrients and, on the other hand, causes DNA damage that facilitates the appearance of mutations with the ability to confer reentry into the cell cycle under conditions that normally prevent growth. In fact, the sod1 deletion mutant is one of the mutants from the yeast knockout collection with the highest spontaneous mutation frequency. Importantly, the long-lived mutants, which are better protected against superoxide damage (including DNA damage), generally do not show adaptive regrowth, in agreement with a role for superoxide and protective systems in preventing the conditions necessary to achieve regrowth. Further analysis of yeast apoptosis during chronological aging has revealed that the pH of the medium affects cell survival. By day 3 the pH of the culture for cells grown in SDC medium of yeast cultures reaches 3 to 3.5. After adjustment to 6 to 7, the survival of the culture is significantly extended. In mammals the release of cytochrome c that triggers the caspase cascade activation in apoptotic cells is preceded by mitochondrial alkalinization and cytosol acidification. Cytochrome c release has also been observed in yeast treated with acetic acid, alpha factor, or overexpressing mammalian BAX, although its function in apoptosis activation has not been established yet. A possibility that needs to be investigated is whether the extracellular and consequently intracellular acidification observed in yeast aging cultures triggers apoptosis via the release of cytochrome c. In agreement with the role for a switch to water in doubling the survival, we determined that ethanol is an important promoter of agedependent PCD in yeast. This carbon source is normally accumulated during fermentative growth but is not rapidly depleted in chronologically aging cultures of wild-type cells, at least in certain genetic backgrounds such as DBY746. When ethanol is removed from the incubation medium by evaporation, a significant life span extension is observed. Moreover, ethanol addition to cultures switched to water rapidly kills the yeast, suggesting an active role of ethanol in the activation of the death program in nondividing cultures, but also in the absence of all the nutrients required for growth. Recent work by Allen et al. (2006) has characterized yeast stationary phase cultures grown in rich medium by using an equilibrium density-gradient centrifugation method. After 24 hours from the inoculation, they could
394 |
VALTER D. LONGO AND CRISTINA MAZZONI |
separate the cells in two fractions. The density of the lower fraction (high-density) increased steadily until day 7. The characterization of the two fractions revealed the following: (1) the high-density cells were mostly unbudded and showed several features of quiescent cells, whereas the low-density cells were both budded and unbudded and morphologically more similar to dividing cells (nonquiescent); (2) the low-density cells lost viability more rapidly than the others, were more sensitive to heat-shock, and produced more ROS than the quiescent cells; and (3) quiescent cells showed higher levels of apoptotic markers (DNA fragmentation and phosphatidylserine exposure) than non-quiescent cells.
It will be very important to continue to study the dynamics of the two types of cells to establish whether their ratio changes over time and whether quiescent cells become non-quiescent once the apoptotic program is activated. The apoptotic features described previously for the non-quiescent cells resemble those observed in wild-type cells aging chronologically in glucose/ethanol, suggesting the presence of non-quiescent cells in these cultures as well.
Adaptive regrowth therefore could represent a form of kin selection or group selection, with clear implication in relation to the aging theory. Thus an adaptive death program in the context of microbial populations is plausible and should be considered in parallel with classical evolutionary theories. Although natural selection primarily acts to increase the fitness of an individual, a multilevel selection process may more accurately reflect the complexity of the selection process, which must account for a population-based death program that appears to play a central role in the fitness of microbial populations. Notably, programmed aging/adaptive regrowth is only one of the strategies available to yeast populations to overcome periods of starvation. As mentioned earlier, incubation in water promotes life span extension and high levels of stress resistance, in agreement with the activation of a “survival program” that benefits all the individual yeast cells. Adaptive regrowth is observed also in budding yeast isolated from the natural environment, indicating that it is unlikely that the studies described above reflect only laboratory genotypes. Moreover, when laboratory strains are grown in grape extract (a medium that better reflects the natural environment for yeast), the survival curves and regrowth pattern are very similar to those obtained in glucose medium, strongly suggesting that adaptive regrowth is not an artifact owing to the use of synthetic medium.
Schizosaccharomyces pombe shares several similarities with S. cerevisiae in terms of chronological aging and its regulation. Although fewer studies have been
performed on PCD in S. pombe, apoptotic markers have been detected in cells expressing BAX/BAK and in mutants lacking the enzymes responsible for the biosynthesis of triacylglycerol. Furthermore, a homolog of the budding yeast meta-caspase Yca1 has been identified in the S. pombe genome. With respect to chronological aging, fission yeast show activation of meta-caspase activity, which is reduced in the long-lived pka1 and sck2 mutants (PKA and SCK2 are homologs of S. cerevisiae PKA and SCH9, respectively). Although still preliminary, these results and the conservation of the life regulatory pathways in the two yeast species suggests that an aging program and possibly adaptive regrowth also may be common among many yeast species.
SUGGESTED READINGS
Ahn, S. H., Henderson, K. A., Keeney, S. and Allis, C. D. (2005). H2B (Ser10) phosphorylation is induced during apoptosis and meiosis in S. cerevisiae. Cell Cycle 4, 780–3.
Allen, C., Buttner, S., Aragon, A. D., Thomas, J. A., Meirelles, O., Jaetao, J. E., Benn, D., Ruby, S. W., Veenhuis, M., Madeo, F. and Werner-Washburne, M. (2006). Isolation of quiescent and nonquiescent cells from yeast stationary-phase cultures.
J Cell Biol 174, 89–100.
Almeida, B., Buttner, S., Ohlmeier, S., Silva, A., Mesquita, A., Sampaio-Marques, B., Osorio, N. S., Kollau, A., Mayer, B., Leao, C., Laranjinha, J., Rodrigues, F., Madeo, F. and Ludovico, P. (2007). NO-mediated apoptosis in yeast. J Cell Sci 120, 3279– 88.
Almeida, B., Silva, A., Mesquita, A., Sampaio-Marques, B., Rodrigues, F. and Ludovico, P. (2008). Drug-induced apoptosis in yeast. Biochim Biophys Acta 1783, 1436–48.
Braun, R. J. and Zischka, H. (2008). Mechanisms of Cdc48/VCPmediated cell death – from yeast apoptosis to human disease.
Biochim Biophys Acta 1783, 1418–35.
Cannon, J. F., Gibbs, J. B. and Tatchell, K. (1986). Suppressors of the ras2 mutation of Saccharomyces cerevisiae. Genetics 113, 247–64.
Dujon, B. (1996). The yeast genome project: what did we learn?
Trends Genet 12, 263–70.
Fabrizio, P., Battistella, L., Vardavas, R., Gattazzo, C., Liou, L. L., Diaspro, A., Dossen, J. W., Gralla, E. B. and Longo, V. D. (2004a). Superoxide is a mediator of an altruistic aging program in Saccharomyces cerevisiae. J Cell Biol 166, 1055–67.
Fabrizio, P., Gattazzo, C., Battistella, L., Wei, M., Cheng, C., McGrew, K. and Longo, V. D. (2005). Sir2 blocks extreme lifespan extension. Cell 123, 655–67.
Fabrizio, P., Liou, L. L., Moy, V. N., Diaspro, A., Valentine, J. S., Gralla, E. B. and Longo, V. D. (2003). SOD2 functions downstream of Sch9 to extend longevity in yeast. Genetics 163, 35–46.
Fabrizio, P., Pletcher, S. D., Minois, N., Vaupel, J. W. and Longo, V. D. (2004b). Chronological aging-independent replicative
PROGRAMMED CELL DEATH IN THE YEAST SACCHAROMYCES CEREVISIAE |
395 |
life span regulation by Msn2/Msn4 and Sod2 in Saccharomyces cerevisiae. FEBS Lett 557, 136–42.
Fabrizio, P., Pozza, F., Pletcher, S. D., Gendron, C. M. and Longo, V. D. (2001). Regulation of longevity and stress resistance by Sch9 in yeast. Science 292, 288–90.
Fahrenkrog, B., Sauder, U. and Aebi, U. (2004). The S. cerevisiae HtrA-like protein Nma111p is a nuclear serine protease that mediates yeast apoptosis. J Cell Sci 117, 115–26.
Fannjiang, Y., Cheng, W. C., Lee, S. J., Qi, B., Pevsner, J., McCaffery, J. M., Hill, R. B., Basanez, G. and Hardwick, J. M. (2004). Mitochondrial fission proteins regulate programmed cell death in yeast. Genes Dev 18, 2785–97.
Foland, T. B., Dentler, W. L., Suprenant, K. A., Gupta, M. L., Jr. and Himes, R. H. (2005). Paclitaxel-induced microtubule stabilization causes mitotic block and apoptotic-like cell death in a paclitaxel-sensitive strain of Saccharomyces cerevisiae.
Yeast 22, 971–8.
Forman, M. S., Mackenzie, I. R., Cairns, N. J., Swanson, E., Boyer, P. J., Drachman, D. A., Jhaveri, B. S., Karlawish, J. H., Pestronk, A., Smith, T. W., Tu, P. H., Watts, G. D., Markesbery, W. R., Smith, C. D. and Kimonis, V. E. (2006). Novel ubiquitin neuropathology in frontotemporal dementia with valosincontaining protein gene mutations. J Neuropathol Exp Neurol
65, 571–81.
Frohlich, K. U., Fussi, H. and Ruckenstuhl, C. (2007). Yeast apoptosis–from genes to pathways. Semin Cancer Biol 17, 112–21.
Goffeau, A., Barrell, B. G., Bussey, H., Davis, R. W., Dujon, B., Feldmann, H., Galibert, F., Hoheisel, J. D., Jacq, C., Johnston, M., Louis, E. J., Mewes, H. W., Murakami, Y., Philippsen, P., Tettelin, H. and Oliver, S. G. (1996). Life with 6000 genes.
Science 274, 546, 563–7.
Hanada, M., Aime-Sempe, C., Sato, T. and Reed, J. C. (1995). Structure-function analysis of Bcl-2 protein. Identification of conserved domains important for homodimerization with Bcl-2 and heterodimerization with Bax. J Biol Chem 270, 11962–9.
Herker, E., Jungwirth, H., Lehmann, K. A., Maldener, C., Frohlich, K. U., Wissing, S., Buttner, S., Fehr, M., Sigrist, S. and Madeo, F. (2004). Chronological aging leads to apoptosis in yeast. J Cell Biol 164, 501–7.
Higashiyama, H., Hirose, F., Yamaguchi, M., Inoue, Y. H., Fujikake, N., Matsukage, A. and Kakizuka, A. (2002). Identification of ter94, Drosophila VCP, as a modulator of polyglutamine-induced neurodegeneration. Cell Death Differ
9, 264–73.
Hirabayashi, M., Inoue, K., Tanaka, K., Nakadate, K., Ohsawa, Y., Kamei, Y., Popiel, A. H., Sinohara, A., Iwamatsu, A., Kimura, Y., Uchiyama, Y., Hori, S. and Kakizuka, A. (2001). VCP/p97 in abnormal protein aggregates, cytoplasmic vacuoles, and cell death, phenotypes relevant to neurodegeneration. Cell Death Differ 8, 977–84.
Huang, M. E., Rio, A. G., Nicolas, A. and Kolodner, R. D. (2003). A genomewide screen in Saccharomyces cerevisiae for genes that suppress the accumulation of mutations. Proc Natl Acad Sci U S A 100, 11529–34.
Hubbers, C. U., Clemen, C. S., Kesper, K., Boddrich, A., Hofmann, A., Kamarainen, O., Tolksdorf, K., Stumpf, M., Reichelt, J., Roth, U., Krause, S., Watts, G., Kimonis, V., Wattjes, M. P., Reimann, J., Thal, D. R., Biermann, K., Evert, B. O., Lochmuller, H., Wanker, E. E., Schoser, B. G., Noegel, A. A. and Schroder, R. (2007). Pathological consequences of VCP mutations on human striated muscle. Brain 130, 381–93.
Imamura, S., Ojima, N. and Yamashita, M. (2003). Coldinducible expression of the cell division cycle gene CDC48 and its promotion of cell proliferation during cold acclimation in zebrafish cells. FEBS Lett 549, 14–20.
Ivanovska, I. and Hardwick, J. M. (2005). Viruses activate a genetically conserved cell death pathway in a unicellular organism. J Cell Biol 170, 391–9.
Lamb, J. R., Fu, V., Wirtz, E. and Bangs, J. D. (2001). Functional analysis of the trypanosomal AAA protein TbVCP with trans-dominant ATP hydrolysis mutants. J Biol Chem 276, 21512–20.
Li, W., Sun, L., Liang, Q., Wang, J., Mo, W. and Zhou, B. (2006). Yeast AMID homologue Ndi1p displays respiration-restricted apoptotic activity and is involved in chronological aging. Mol Biol Cell 17, 1802–11.
Liang, Q., Li, W. and Zhou, B. (2008). Caspase-independent apoptosis in yeast. Biochim Biophys Acta 1783, 1311–9.
Ligr, M., Madeo, F., Frohlich, E., Hilt, W., Frohlich, K. U. and Wolf, D. H. (1998). Mammalian Bax triggers apoptotic changes in yeast. FEBS Lett 438, 61–5.
Longo, V. D., Ellerby, L. M., Bredesen, D. E., Valentine, J. S. and Gralla, E. B. (1997). Human Bcl-2 reverses survival defects in yeast lacking superoxide dismutase and delays death of wildtype yeast. J Cell Biol 137, 1581–8.
Longo, V. D., Gralla, E. B. and Valentine, J. S. (1996). Superoxide dismutase activity is essential for stationary phase survival in Saccharomyces cerevisiae. Mitochondrial production of toxic oxygen species in vivo. J Biol Chem 271, 12275–80.
Longo, V. D., Mitteldorf, J. and Skulachev, V. P. (2005). Programmed and altruistic ageing. Nat Rev Genet 6, 866–72.
Low, C. P., Liew, L. P., Pervaiz, S. and Yang, H. (2005). Apoptosis and lipoapoptosis in the fission yeast Schizosaccharomyces pombe. FEMS Yeast Res 5, 1199–206.
Ludovico, P., Sousa, M. J., Silva, M. T., Leao, C. and CorteReal, M. (2001). Saccharomyces cerevisiae commits to a programmed cell death process in response to acetic acid. Microbiology 147, 2409–15.
Madeo, F., Frohlich, E. and Frohlich, K. U. (1997). A yeast mutant showing diagnostic markers of early and late apoptosis. J Cell Biol 139, 729–34.
Madeo, F., Frohlich, E., Ligr, M., Grey, M., Sigrist, S. J., Wolf, D. H. and Frohlich, K. U. (1999). Oxygen stress: a regulator of apoptosis in yeast. J Cell Biol 145, 757–67.
Madeo, F., Herker, E., Maldener, C., Wissing, S., Lachelt, S., Herlan, M., Fehr, M., Lauber, K., Sigrist, S. J., Wesselborg, S. and Frohlich, K. U. (2002). A caspase-related protease regulates apoptosis in yeast. Mol Cell 9, 911–7.
Matsuyama, S., Llopis, J., Deveraux, Q. L., Tsien, R. Y. and Reed, J. C. (2000). Changes in intramitochondrial and cytosolic pH:
396 |
VALTER D. LONGO AND CRISTINA MAZZONI |
early events that modulate caspase activation during apoptosis. Nat Cell Biol 2, 318–25.
Mazzoni, C. and Falcone, C. (2008). Caspase-dependent apoptosis in yeast. Biochim Biophys Acta 1783, 1320–7.
Mazzoni, C., Herker, E., Palermo, V., Jungwirth, H., Eisenberg, T., Madeo, F. and Falcone, C. (2005). Yeast caspase 1 links messenger RNA stability to apoptosis in yeast. EMBO Rep 6, 1076– 81.
Mazzoni, C., Mancini, P., Verdone, L., Madeo, F., Serafini, A., Herker, E. and Falcone, C. (2003). A truncated form of KlLsm4p and the absence of factors involved in mRNA decapping trigger apoptosis in yeast. Mol Biol Cell 14, 721–9.
Palermo, V., Falcone, C. and Mazzoni, C. (2007). Apoptosis and aging in mitochondrial morphology mutants of S. cerevisiae.
Folia Microbiol (Praha) 52, 479–83.
Pozniakovsky, A. I., Knorre, D. A., Markova, O. V., Hyman, A. A., Skulachev, V. P. and Severin, F. F. (2005). Role of mitochondria in the pheromoneand amiodarone-induced programmed death of yeast. J Cell Biol 168, 257–69.
Priault, M., Chaudhuri, B., Clow, A., Camougrand, N. and Manon, S. (1999). Investigation of bax-induced release of cytochrome c from yeast mitochondria permeability of mitochondrial membranes, role of VDAC and ATP requirement.
Eur J Biochem 260, 684–91.
Qiu, J., Yoon, J. H. and Shen, B. (2005). Search for apoptotic nucleases in yeast: role of Tat-D nuclease in apoptotic DNA degradation. J Biol Chem 280, 15370–9.
Reiter, J., Herker, E., Madeo, F. and Schmitt, M. J. (2005). Viral killer toxins induce caspase-mediated apoptosis in yeast. J Cell Biol 168, 353–8.
Roux, A. E., Quissac, A., Chartrand, P., Ferbeyre, G. and Rokeach, L. A. (2006). Regulation of chronological aging in Schizosaccharomyces pombe by the protein kinases Pka1 and Sck2.
Aging Cell 5, 345–57.
Sato, T., Hanada, M., Bodrug, S., Irie, S., Iwama, N., Boise, L. H., Thompson, C. B., Golemis, E., Fong, L., Wang, H. G. and et al. (1994). Interactions among members of the Bcl-2 protein family analyzed with a yeast two-hybrid system. Proc Natl Acad Sci U S A 91, 9238–42.
Schmitt, M. J. and Breinig, F. (2006). Yeast viral killer toxins: lethality and self-protection. Nat Rev Microbiol 4, 212–21.
Severin, F. F. and Hyman, A. A. (2002). Pheromone induces programmed cell death in S. cerevisiae. Curr Biol 12, R233–5.
Shirogane, T., Fukada, T., Muller, J. M., Shima, D. T., Hibi, M. and Hirano, T. (1999). Synergistic roles for Pim-1 and c-Myc in STAT3-mediated cell cycle progression and antiapoptosis.
Immunity 11, 709–19.
Silva, R. D., Sotoca, R., Johansson, B., Ludovico, P., Sansonetty, F., Silva, M. T., Peinado, J. M. and Corte-Real, M. (2005). Hyperosmotic stress induces metacaspaseand mitochondria-dependent apoptosis in Saccharomyces cerevisiae. Mol Microbiol 58, 824–34.
Teparic, R., Stuparevic, I. and Mrsa, V. (2004). Increased mortality of Saccharomyces cerevisiae cell wall protein mutants.
Microbiology 150, 3145–50.
Vachova, L. and Palkova, Z. (2005). Physiological regulation of yeast cell death in multicellular colonies is triggered by ammonia. J Cell Biol 169, 711–7.
Wilson, M. A., St. Amour, C. V., Collins, J. L., Ringe, D. and Petsko, G. A. (2004). The 1.8-A resolution crystal structure of YDR533Cp from Saccharomyces cerevisiae: a member of the DJ-1/ThiJ/PfpI superfamily. Proc Natl Acad Sci U S A 101, 1531–6.
Wissing, S., Ludovico, P., Herker, E., Buttner, S., Engelhardt, S. M., Decker, T., Link, A., Proksch, A., Rodrigues, F., Corte-Real, M., Frohlich, K. U., Manns, J., Cande, C., Sigrist, S. J., Kroemer, G. and Madeo, F. (2004). An AIF orthologue regulates apoptosis in yeast. J Cell Biol 166, 969–74.
Zhang, N. N., Dudgeon, D. D., Paliwal, S., Levchenko, A., Grote, E. and Cunningham, K. W. (2006). Multiple signaling pathways regulate yeast cell death during the response to mating pheromones. Mol Biol Cell 17, 3409–22.
Zhang, Q., Chieu, H. K., Low, C. P., Zhang, S., Heng, C. K. and Yang, H. (2003). Schizosaccharomyces pombe cells deficient in triacylglycerols synthesis undergo apoptosis upon entry into the stationary phase. J Biol Chem 278, 47145–55.